Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
Mayo Clinic, Phoenix, Arizona University of Southern California, Los Angeles, California Mayo Clinic, Jacksonville, Florida Northwestern University, Chicago, Illinois Mayo Clinic, Rochester, Minnesota Atlantic Health System Hospital, Morristown, New Jersey Mary Crowley Cancer Research, Dallas, Texas South Korea
National Cancer Center, Goyang-si CHA University Bundang Medical Center, Seongnam-si Asan Medical Center, Seoul Severance Hospital, Seoul